[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS5220A - Cyclo-oxygenase-2 selective carprofen for the treatment of pain and inflammation in dogs - Google Patents

Cyclo-oxygenase-2 selective carprofen for the treatment of pain and inflammation in dogs

Info

Publication number
IS5220A
IS5220A IS5220A IS5220A IS5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A
Authority
IS
Iceland
Prior art keywords
carprofen
oxygenase
cyclo
dogs
inflammation
Prior art date
Application number
IS5220A
Other languages
Icelandic (is)
Inventor
Marie Lundy Kristin
Paul Ricketts Anthony
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS5220A publication Critical patent/IS5220A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
IS5220A 1997-05-05 1999-10-19 Cyclo-oxygenase-2 selective carprofen for the treatment of pain and inflammation in dogs IS5220A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
IS5220A true IS5220A (en) 1999-10-19

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5220A IS5220A (en) 1997-05-05 1999-10-19 Cyclo-oxygenase-2 selective carprofen for the treatment of pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (en)
JP (1) JP2000513020A (en)
KR (2) KR20040004406A (en)
CN (1) CN1255059A (en)
AP (1) AP9801234A0 (en)
AR (2) AR011726A1 (en)
AU (1) AU6932198A (en)
BG (1) BG103852A (en)
BR (1) BR9808720A (en)
CA (1) CA2288759A1 (en)
DZ (1) DZ2479A1 (en)
EA (1) EA003696B1 (en)
GT (1) GT199800063A (en)
HR (1) HRP980244A2 (en)
HU (1) HUP0001286A3 (en)
ID (1) ID21311A (en)
IL (1) IL132570A0 (en)
IS (1) IS5220A (en)
MA (1) MA26491A1 (en)
NO (1) NO995389L (en)
NZ (1) NZ500183A (en)
OA (1) OA11213A (en)
PA (1) PA8450601A1 (en)
PE (1) PE72599A1 (en)
PL (1) PL337003A1 (en)
SK (1) SK148199A3 (en)
TN (1) TNSN98059A1 (en)
TW (1) TW590773B (en)
UY (1) UY24989A1 (en)
WO (1) WO1998050033A1 (en)
YU (1) YU55899A (en)
ZA (1) ZA983722B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
NZ513965A (en) * 1999-03-10 2004-04-30 G Method and composition for administering a cyclooxygenase-2 inhibitor
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US20020016342A1 (en) * 2000-05-15 2002-02-07 Edward Scolnick Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
AU6837701A (en) 2000-06-13 2001-12-24 American Home Prod Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
EP1307538B1 (en) 2000-08-07 2009-01-07 Vanderbilt University Detection of cox-2 activity and anandamide metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
PL1745791T3 (en) 2003-05-07 2013-11-29 Osteologix As Treating cartilage/bone conditions with water-soluble strontium salts
BRPI0412581A (en) * 2003-07-31 2006-09-19 Pharmacia & Upjohn Co Llc dispersible formulation of an anti-inflammatory agent
BRPI0610316A2 (en) * 2005-05-20 2010-06-15 Pfizer Ltd Synergistic combinations of non-steroidal anti-inflammatory drugs with alpha-delta ligands
WO2008122965A2 (en) 2007-04-04 2008-10-16 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
CA2685118C (en) 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
SI2432455T1 (en) 2009-05-18 2015-04-30 Sigmoid Pharma Limited Composition comprising oil drops
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
EP3113774B1 (en) 2014-03-06 2022-01-26 Elanco Animal Health Incorporated Compositions of grapiprant and methods for using the same
WO2016071515A1 (en) 2014-11-07 2016-05-12 Sigmoid Pharma Limited Compositions comprising cyclosporin
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
US20230174485A1 (en) * 2020-03-25 2023-06-08 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
PE72599A1 (en) 1999-08-12
CN1255059A (en) 2000-05-31
BR9808720A (en) 2000-07-11
EA003696B1 (en) 2003-08-28
DZ2479A1 (en) 2003-02-01
JP2000513020A (en) 2000-10-03
NZ500183A (en) 2002-04-26
HUP0001286A3 (en) 2000-12-28
BG103852A (en) 2000-06-30
OA11213A (en) 2003-07-14
AR011726A1 (en) 2000-08-30
EP0988034A1 (en) 2000-03-29
TW590773B (en) 2004-06-11
HRP980244A2 (en) 1999-02-28
KR20010012300A (en) 2001-02-15
AR039628A2 (en) 2005-03-02
UY24989A1 (en) 2001-10-25
GT199800063A (en) 1999-10-26
TNSN98059A1 (en) 2005-03-15
WO1998050033A1 (en) 1998-11-12
SK148199A3 (en) 2001-09-11
PL337003A1 (en) 2000-07-31
KR20040004406A (en) 2004-01-13
ZA983722B (en) 1999-11-04
AP9801234A0 (en) 1999-11-04
MA26491A1 (en) 2004-12-20
ID21311A (en) 1999-05-20
YU55899A (en) 2003-08-29
NO995389L (en) 2000-01-04
IL132570A0 (en) 2001-03-19
AU6932198A (en) 1998-11-27
PA8450601A1 (en) 2000-05-24
NO995389D0 (en) 1999-11-04
CA2288759A1 (en) 1998-11-12
EA199900895A1 (en) 2000-06-26
HUP0001286A2 (en) 2000-11-28

Similar Documents

Publication Publication Date Title
IS5220A (en) Cyclo-oxygenase-2 selective carprofen for the treatment of pain and inflammation in dogs
NO20005190L (en) Therapeutic angiogenic factors and methods for their use
NO20014560D0 (en) Quinasolines and their therapeutic use
IS5405A (en) Prostaglandin agonists and their use in the treatment of bone disorders
DE69825447D1 (en) DERMATOLOGICAL TREATMENT DEVICE
IS2107B (en) Arylsulfonamide and their analogues and their use in the treatment of neurodegenerative disorders
IS5921A (en) Substitute Benzopyran analogues for use in the treatment of inflammation
NO20022656L (en) Caspase Inhibitors and Their Use
IS5928A (en) Methods and combinations to prevent drug resistance
NO20004544D0 (en) Improved pumping device and improved methods
ID18741A (en) Nicotinic Substance in Therapy
DE60019490D1 (en) Fuel conveyor and treatment device
IS5504A (en) Composition active in the treatment of impotence
NO983576D0 (en) Well treatment fluids and methods
DE69701250D1 (en) Animal treatment device
IS4628A (en) Cell series that produces pain-relieving substances for use in the treatment of pain
NO20012738D0 (en) Therapeutic products and their use
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
IS5809A (en) Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration
NO326826B1 (en) Alpha-amino acid amides, preparation and therapeutic use thereof
ITMI20001555A0 (en) ELECTROCHEMICAL TREATMENT PROCEDURE AND DEVICE
DK0915655T3 (en) Method and composition for the treatment of parasites in animal environments
DE69932577D1 (en) Bar treatment device and bar charger
IS6428A (en) Method and mix to treat pain
IS5324A (en) (S) 2-Methylamino-2-phenyl-n-butyl 3,4,5-trimethoxy-benzoate, its use in the treatment of chronic pain